Viral epidemics develop from the emergence of new variants of infectious viruses. The lack of effective antiviral treatments for the new viral infections coupled with rapid community spread of the infection often result in major human and financial loss. Viral transmissions can occur via close human‐to‐human contact or via contacting a contaminated surface. Thus, careful disinfection or sanitization is essential to curtail viral spread. A myriad of disinfectants/sanitizing agents/biocidal agents are available that can inactivate viruses, but their effectiveness is dependent upon many factors such as concentration of agent, reaction time, temperature, and organic load. In this work, we review common commercially available disinfectants agents available on the market and evaluate their effectiveness under various application conditions. In addition, this work also seeks to debunk common myths about viral inactivation and highlight new exciting advances in the development of potential sanitizing agents.

No abstract

Anti-vascular endothelial growth factors (anti-VEGF) have become the most common treatment modality for many retinal diseases. These include neovascular age-related macular degeneration (n-AMD), proliferative diabetic retinopathy (PDR) and retinal vein occlusions (RVO). However, these drugs are administered via intravitreal injections that are associated with sight-threatening complications. The most feared of these complications is endophthalmitis, a severe infection of the eye with extremely poor visual outcomes. Patients with retinal diseases typically have to undergo multiple injections before achieving the desired therapeutic effect. Each injection incurs the risk of the sight-threatening complications. As such, there has been great interest in developing sustained delivery platforms for anti-VEGF agents to the posterior segment of the eye. In recent years, there have been various strategies that have been conceptualised. These include non-biodegradable implants, nano-formulations and hydrogels. In this review, the barriers of drug delivery to the posterior segment of the eye will be explained. The characteristics of an ideal sustained delivery platform will then be discussed. Finally, the current available strategies will be analysed with the above-mentioned characteristics in mind to determine the advantages and disadvantages of each sustained drug delivery modality. Through the above, this review attempts to provide an overview of the sustained delivery platforms in their various phases of development.These authors contributed equally: Ivan Seah Yu Jun, Zhao Xin Xin 1234567890();,:1234567890();,:

No abstract

No abstract

Plant electrophysiology lays the foundation for smart plant interrogation and intervention. However, plant trichomes with hair‐like morphologies present topographical features that challenge stable and high‐fidelity non‐invasive electrophysiology, due to the inadequate dynamic shape adaptability of conventional electrodes. Here, this issue is overcome using a morphable ionic electrode based on a thermogel, which gradually transforms from a viscous liquid to a viscoelastic gel. This transformation enables the morphable electrode to lock into the abrupt hairy surface irregularities and establish a conformal and adhesive interface. It achieves down to one tenth of the impedance and 4–5 times the adhesive strengths of conventional hydrogel electrodes on hairy leaves. As a result of the improved electrical and mechanical robustness, the morphable electrode can record more than one order of magnitude higher signal‐to‐noise ratio on hairy plants and maintains high‐fidelity recording despite plant movements, achieving superior performance to conventional hydrogel electrodes. The reported morphable electrode is a promising tool for hairy plant electrophysiology and may be applied to diversely textured plants for advanced sensing and modulation.

Polymeric hydrogels are promising biomaterials to be used as vitreous tamponade in the eye. However, while the clinical need and the required attributes of a vitreous replacement hydrogel are clear, there is a major gap in understanding the various polymer requirements to achieve the “ideal” hydrogel. In this study, we investigated the effect of the polymer molecular weight on polyurethane thermogel properties and found that there is a theoretical minimum number of hydrophobic blocks required for gelation. We then used these polymers as vitreous replacements. We found that there is a preferred molecular weight range, whereby hydrogels with lower molecular weights can cause retinal atrophy and corresponding functional visual loss, while those with higher molecular weights lead to opacity issues. Thermogels in the preferred molecular weight range retained the normal retinal structure and exhibited full visual recovery within 3 months. The effect of the molecular weight was further demonstrated by the effects of postsynthetic autoclaving on the retinal structure and function. The effect of the polymer molecular weight on the functional characteristics of hydrogels demonstrated herein is an important design parameter for polymeric hydrogels for ocular applications.

Metalenses made of artificial sub-wavelength nanostructures have shown the capability of light focusing and imaging with a miniaturized size. Here, we report the demonstration of mass-producible amorphous silicon metalenses on a 12-inch glass wafer via the complementary metal-oxide-semiconductor compatible process. The measured numerical aperture of the fabricated metalens is 0.496 with a focusing spot size of 1.26 μm at the wavelength of 940 nm. The metalens is applied in an imaging system to test the imaging resolution. The minimum bar of the resolution chart with a width of 2.19 μm is clearly observed. Furthermore, the same system demonstrates the imaging of a fingerprint, and proofs the concept of using metalens array to reduce the system size for future compact consumer electronics.